Literature DB >> 28815277

Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.

Theerarat Yimphong1, Teerayut Temtanakitpaisan2, Pranom Buppasiri1, Chompilas Chongsomchai1, Supparaluck Kanchaiyaphum1.   

Abstract

INTRODUCTION AND HYPOTHESIS: To ascertain the rate of discontinuation after vaginal pessary use among pelvic organ prolapse patients.
METHODS: We enrolled women suffering from pelvic organ prolapse who opted to use vaginal pessary as the first line of treatment and were fitted with a pessary at the urogynecological clinic in Khon Kaen University's Srinagarind Hospital (Thailand) during the period between 2010 and 2016. Patients' medical records were retrospectively reviewed. Patients were contacted by telephone if there were missing data or if more information was required.
RESULTS: One hundred and forty women were included. The median age was 71.5 years (interquartile = 65.0, 77.0) and normal vaginal parity was 4.0 (interquartile =3.0, 6.0). The mean ± SD of BMI was 23.5± 3.6 kg/m2. Most of the women enrolled in the study (97.9%) were postmenopausal and many were at an advanced stage of prolapse (73.6%). Support pessaries were the most common treatment (95.0%). The discontinuation rate of pessary use after 1 year was 16.1%. The most common reason for discontinuing the vaginal pessary was frequent expulsion (26.3%). Abnormal vaginal discharge was the most common adverse effect after pessary insertion (17.1%). Lower BMI and history of hysterectomy were the significant risk factors for discontinuation of pessary use (0.76 [95%CI 0.62-0.93] and 15.89 [95%CI 1.67-151.02] respectively).
CONCLUSIONS: The discontinuation rate of pessary use in the case of pelvic organ prolapse was low after 1 year. Abnormal vaginal discharge was the most common adverse side effect. Lower BMI and history of hysterectomy were factors significantly associated with the discontinuation.

Entities:  

Keywords:  Adverse effects; Discontinuation rate; Pelvic organ prolapse; Vaginal pessary

Mesh:

Year:  2017        PMID: 28815277     DOI: 10.1007/s00192-017-3445-x

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  26 in total

1.  Gynecologists' patterns of prescribing pessaries.

Authors:  E Pott-Grinstein; J R Newcomer
Journal:  J Reprod Med       Date:  2001-03       Impact factor: 0.142

2.  [Factors influencing therapy decision in patients with severe pelvic organ prolapse].

Authors:  Yu Wang; Junfang Yang; Jinsong Han; Fuli Zhu; Kun Zhang; Ying Yao
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2015-02

3.  Predictors of successful pessary fitting and continued use in a nurse-midwifery pessary clinic.

Authors:  Jennifer M Maito; Zellisha A Quam; Ellen Craig; Kara A Danner; Rebecca G Rogers
Journal:  J Midwifery Womens Health       Date:  2006 Mar-Apr       Impact factor: 2.388

4.  Vaginal pessaries and their use in pelvic relaxation.

Authors:  P J Sulak; T J Kuehl; B L Shull
Journal:  J Reprod Med       Date:  1993-12       Impact factor: 0.142

5.  Use of a pessary in treatment of pelvic organ prolapse: quality of life, compliance, and failure at 1-year follow-up.

Authors:  Po-Chun Ko; Tsia-Shu Lo; Ling-Hong Tseng; Yi-Hao Lin; Ching-Chung Liang; Shu-Jane Lee
Journal:  J Minim Invasive Gynecol       Date:  2011 Jan-Feb       Impact factor: 4.137

6.  The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care.

Authors:  S E Swift
Journal:  Am J Obstet Gynecol       Date:  2000-08       Impact factor: 8.661

7.  Clinical use of ring with support pessary for advanced pelvic organ prolapse and predictors of its short-term successful use.

Authors:  Mou Deng; Jing Ding; Fangfang Ai; Lan Zhu
Journal:  Menopause       Date:  2017-08       Impact factor: 2.953

8.  Long-term vaginal ring pessary use: discontinuation rates and adverse events.

Authors:  S Sarma; T Ying; K H Moore
Journal:  BJOG       Date:  2009-12       Impact factor: 6.531

9.  Patient characteristics that are associated with continued pessary use versus surgery after 1 year.

Authors:  Jeffrey L Clemons; Vivian C Aguilar; Eric R Sokol; Neil D Jackson; Deborah L Myers
Journal:  Am J Obstet Gynecol       Date:  2004-07       Impact factor: 8.661

Review 10.  Pessary treatment for pelvic organ prolapse and health-related quality of life: a review.

Authors:  Babet H C Lamers; Bart M W Broekman; Alfredo L Milani
Journal:  Int Urogynecol J       Date:  2011-04-07       Impact factor: 2.894

View more
  5 in total

1.  Effectiveness of ring pessaries versus vaginal hysterectomy for advanced pelvic organ prolapse. A cohort study.

Authors:  Alessio Miceli; José-Luis Dueñas-Diez
Journal:  Int Urogynecol J       Date:  2019-03-12       Impact factor: 2.894

2.  Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study.

Authors:  Danielle I Niigaki; Rebecca S P Silva; Maria Augusta Tezelli Bortolini; Fátima F Fitz; Rodrigo A Castro
Journal:  Int Urogynecol J       Date:  2022-03-14       Impact factor: 1.932

Review 3.  The effect of pelvic floor muscle training for women with pelvic organ prolapse: a meta-analysis.

Authors:  Ting Wang; Zhengfang Wen; Meng Li
Journal:  Int Urogynecol J       Date:  2022-03-21       Impact factor: 1.932

4.  Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.

Authors:  José Luis Dueñas; Alessio Miceli
Journal:  Int Urogynecol J       Date:  2018-02-24       Impact factor: 2.894

5.  Theoretical and practical development of the TOPSY self-management intervention for women who use a vaginal pessary for pelvic organ prolapse.

Authors:  Lucy Dwyer; Carol Bugge; Suzanne Hagen; Kirsteen Goodman; Wael Agur; Melanie Dembinsky; Margaret Graham; Karen Guerrero; Christine Hemming; Aethele Khunda; Doreen McClurg; Lynn Melone; Ranee Thakar; Rohna Kearney
Journal:  Trials       Date:  2022-09-05       Impact factor: 2.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.